Bambusa Therapeutics, Inc. (BBTX) stock
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.09−0.66 (-3.94%)
Close on Nov 13, 2026Market cap –P/E –Yield –
Statistics
No statistics for Bambusa Therapeutics yet
Statistics are calculated from the financial statements Bambusa Therapeutics files with the SEC and the daily share price.
See a number that looks wrong?